Literature DB >> 1915258

Identification of 3- and 4-repeat tau isoforms within the PHF in Alzheimer's disease.

R Jakes1, M Novak, M Davison, C M Wischik.   

Abstract

The microtubule associated protein tau is incorporated into the pronase resistant core of the paired helical filament (PHF) in such a way that the repeat region is protected from proteases, but can be released as a major 12 kDa species from the PHF core by formic acid treatment and by boiling in SDS. This fragment retains the ability to aggregate in the presence of SDS. Detailed sequence analysis of the 12 kDa species shows that it consists of a mixture of peptides derived from the repeat region of 3- and 4-repeat tau isoforms comigrating as a single electrophoretic band. However, the 4-repeat isoforms released from the core lack either the first or the last repeat. The pronase-protected region of tau within the PHF core is therefore restricted to three repeats, regardless of isoform. The alignment of cleavage sites at homologous positions within tandem repeats after protease treatment indicates that the tau-core association is precisely constrained by the tandem repeat structure of the tau molecule.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915258      PMCID: PMC452980          DOI: 10.1002/j.1460-2075.1991.tb07820.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  26 in total

1.  Paired helical filaments in electron microscopy of Alzheimer's disease.

Authors:  M KIDD
Journal:  Nature       Date:  1963-01-12       Impact factor: 49.962

2.  Peptides corresponding to the second repeated sequence in MAP-2 inhibit binding of microtubule-associated proteins to microtubules.

Authors:  J C Joly; D L Purich
Journal:  Biochemistry       Date:  1990-09-25       Impact factor: 3.162

3.  Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study.

Authors:  W Bondareff; C M Wischik; M Novak; W B Amos; A Klug; M Roth
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

4.  SDS microslab linear gradient polyacrylamide gel electrophoresis.

Authors:  P T Matsudaira; D R Burgess
Journal:  Anal Biochem       Date:  1978-07-01       Impact factor: 3.365

5.  Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51.

Authors:  M Novak; R Jakes; P C Edwards; C Milstein; C M Wischik
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

6.  Competitive ELISA for the measurement of tau protein in Alzheimer's disease.

Authors:  C R Harrington; P C Edwards; C M Wischik
Journal:  J Immunol Methods       Date:  1990-12-05       Impact factor: 2.303

7.  Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes.

Authors:  P Matsudaira
Journal:  J Biol Chem       Date:  1987-07-25       Impact factor: 5.157

8.  Tau in Alzheimer neurofibrillary tangles. N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site.

Authors:  J P Brion; D P Hanger; M T Bruce; A M Couck; J Flament-Durand; B H Anderton
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

9.  Phosphorylation of microtubule-associated protein tau: identification of the site for Ca2(+)-calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles.

Authors:  B Steiner; E M Mandelkow; J Biernat; N Gustke; H E Meyer; B Schmidt; G Mieskes; H D Söling; D Drechsel; M W Kirschner; M Goedert; E Mandelkow
Journal:  EMBO J       Date:  1990-11       Impact factor: 11.598

10.  Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization.

Authors:  M Goedert; R Jakes
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

View more
  33 in total

1.  Site-specific dynamic nuclear polarization of hydration water as a generally applicable approach to monitor protein aggregation.

Authors:  Anna Pavlova; Evan R McCarney; Dylan W Peterson; Frederick W Dahlquist; John Lew; Songi Han
Journal:  Phys Chem Chem Phys       Date:  2009-06-29       Impact factor: 3.676

2.  Alternative conformations of the Tau repeat domain in complex with an engineered binding protein.

Authors:  Clara S R Grüning; Ewa A Mirecka; Antonia N Klein; Eckhard Mandelkow; Dieter Willbold; Stephen F Marino; Matthias Stoldt; Wolfgang Hoyer
Journal:  J Biol Chem       Date:  2014-06-25       Impact factor: 5.157

3.  Fibers of tau fragments, but not full length tau, exhibit a cross beta-structure: implications for the formation of paired helical filaments.

Authors:  A M Giannetti; G Lindwall; M F Chau; M J Radeke; S C Feinstein; L A Kohlstaedt
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

Review 4.  Intrinsically disordered proteins in the neurodegenerative processes: formation of tau protein paired helical filaments and their analysis.

Authors:  Rostislav Skrabana; Jozef Sevcik; Michal Novak
Journal:  Cell Mol Neurobiol       Date:  2006-06-16       Impact factor: 5.046

5.  Tau protein assembles into isoform- and disulfide-dependent polymorphic fibrils with distinct structural properties.

Authors:  Yoshiaki Furukawa; Kumi Kaneko; Nobuyuki Nukina
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

6.  Immunological characterization of epitopes on tau of Alzheimer's type and chemically modified tau.

Authors:  G Farías; C González-Billault; R B Maccioni
Journal:  Mol Cell Biochem       Date:  1997-03       Impact factor: 3.396

7.  Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines.

Authors:  C M Wischik; P C Edwards; R Y Lai; M Roth; C R Harrington
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

8.  Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure.

Authors:  John Berriman; Louise C Serpell; Keith A Oberg; Anthony L Fink; Michel Goedert; R Anthony Crowther
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-09       Impact factor: 11.205

9.  Therapeutic perspectives of drugs targeting Toll-like receptors based on immune physiopathology theory of Alzheimer's disease.

Authors:  Andrew R Schneider; Youssef Sari
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

10.  Hyperphosphorylation and aggregation of Tau in laforin-deficient mice, an animal model for Lafora disease.

Authors:  Rajat Puri; Toshimitsu Suzuki; Kazuhiro Yamakawa; Subramaniam Ganesh
Journal:  J Biol Chem       Date:  2009-06-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.